Morepen Laboratories Limited (NSE:MOREPENLAB) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But that doesn't change the fact that the returns over the last ...
When Morepen Laboratories Limited’s (NSEI:MOREPENLAB) announced its latest earnings (31 March 2017), I wanted to understand how these figures stacked up against its past performance. The two ...
Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June quarter of the financial year 2021-22, while its share price gained around 3 per cent Morepen ...
Dr. Morepen Ltd., a wholly-owned subsidiary of Morepen Laboratories Ltd., is setting up a first of its kind healthcare chain in India by the name of "Dr. Morepen NOW" in the area of preventive ...
Press Trust of India on MSN
Facing Modern-Day Pressures with Vigour and Vitality
In today's fast-paced world, the demands on our bodies and minds seem never-ending ...
Funding Innovation and Growth via Capacity Expansion for Future endeavor August 7, 2024, Gurugram (Haryana): Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288), proudly announces the ...
Mumbai: Morepen Labs is considering a business rejig which could lead to a potential sale of the over-the-counter brands, including antiseptic cream Burnol, people directly familiar with the matter ...
MUMBAI, Sept 20 (Reuters) - Drug maker Morepen Laboratories Ltd said on Thursday it had lowered the allotment price for a near-15 percent stake sale to a unit of U.S.-based Avenue Capital Group, in ...
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We’ll show how you can use Morepen Laboratories Limited’s (NSE:MOREPENLAB) P/E ratio to inform your ...
Morepen Laboratories is in advanced discussions to sell its over the counter (OTC) business to Piramal Enterprises. The firm has hired consulting firm Deloitte to find buyers for its OTC business, ...
Seamless reading experience. Save your favourite. Get updates on your preferred social platform Follow us for the latest news, insider access to events and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results